Table of Contents
Some Kentuckians don’t start medication-assisted treatment, not because it’s unavailable, but because of what they think they know. Old ideas about Suboxone, telehealth, and recovery keep them from trying something that works.
This article clears up the common myths about remote opioid addiction care and support in Kentucky with facts that speak for themselves.
Myth 1: Suboxone Just Replaces One Addiction with Another
The idea that Suboxone just swaps one addiction for another is a myth. Buprenorphine is a partial agonist with a ceiling effect – no euphoria at higher doses. A prescribed dose for a chronic condition is not an addiction. Suboxone is FDA-approved and proven to cut overdose deaths and emergency room visits.
Myth 2: Telehealth Treatment Is Less Legitimate Than In Person Care
A video visit is still a real treatment. Research on rural opioid programs found retention and medication adherence were comparable to in-person care. The same providers, same licenses, same prescribing rules. The only thing that changes is the commute.
Myth 3: Only A Specialist Can Prescribe Suboxone
There is a lingering belief that only special providers can prescribe Suboxone. That came from the old X waiver requirement, but it was eliminated.
Now any licensed provider can prescribe it. That change has made treatment more accessible, including via telehealth in Kentucky.
Myth 4: Medicaid Patients Can’t Get Treatment Started Remotely
This myth has roots in a real gap, but it doesn’t reflect current policy. Medicaid patients initially started buprenorphine via telehealth at lower rates than others, due to provider participation, rather than coverage limits.
Kentucky Medicaid covers buprenorphine and telehealth, and most plans do not require prior authorization to begin treatment.
Myth 5: Telehealth Doesn’t Work In Rural Or Mountainous Parts Of Kentucky
Geography sounds like an obvious barrier, but the real limitation in Eastern Kentucky has been a shortage of providers, not remote care itself. Once a patient has phone or internet access, they can reach the same provider and medications as someone in a city.
What Actually Limits Access in These Areas
These factors matter more than distance:
- Unreliable broadband or cell coverage
- Older patients may be less familiar with video
- Some local pharmacies do not stock buprenorphine
How Programs Work Around These Gaps
There are workable fixes:
- Audio-only visits are allowed when video is not available
- Prescriptions go to pharmacies that have supply
- Care coordinators or family can help with technology
The gaps are closing. Treatment is reaching more people.
Myth 6: Treatment Has To Continue Forever Or It “Doesn’t Count”
There is a common assumption that MAT only counts if you eventually stop. No other chronic condition is held to that standard. Buprenorphine does not come with a required end date. Some people taper off, others stay on it for years because it works. Both are recognized as valid outcomes by addiction medicine.
Myth 7: Going Through A Telehealth Provider Means Losing Your Local Pharmacy Or Doctor
People often fear virtual treatment means starting all over. That is not how it works. Your pharmacy stays the same. Your primary care doctor stays the same. The telehealth provider just adds another layer of support, not a new system.
What This Means For Kentuckians Considering Treatment
These misconceptions matter because each one is a reason someone delays getting help they could already access.
- Suboxone is medically legitimate, not a swap of one drug for another.
- Telehealth follows the same clinical standards as in-person care.
- More providers can prescribe Suboxone since the X-waiver ended.
- Kentucky Medicaid covers telehealth buprenorphine without the barriers some expect.
- Rural areas can access the same quality of care as cities.
For Kentuckians looking into remote opioid treatment and addiction care and support in Kentucky, a licensed provider like Aegis Medical USA can clarify coverage and treatment before any commitment.
